Back BSP study outcome published in Pharmeuropa Bio & Scientific Notes – Human tetanus immunoglobulin BRP batch 2

EDQM Strasbourg, France 29/01/2024
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
BSP study outcome published in Pharmeuropa Bio & Scientific Notes – Human tetanus immunoglobulin BRP batch 2

The outcome of the Biological Standardisation Programme study BSP140 to establish the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for Human tetanus immunoglobulin batch 2 has been published in the online journal Pharmeuropa Bio & Scientific Notes of the European Directorate for the Quality of Medicines & HealthCare (EDQM).

The BSP140 study was run in the context of a joint EDQM-BSP/WHO-MHRA project for the establishment of replacement batches of the harmonised Ph. Eur. and World Health Organization reference standards for this product.

See also: